Sample text for Dangerous doses : how counterfeiters are contaminating America's drug supply / Katherine Eban.


Bibliographic record and links to related information available from the Library of Congress catalog


Copyrighted sample text provided by the publisher and used with permission. May be incomplete or contain other coding.


Counter
1. A Victim of Success

January 2002
Miami, Florida

ABOARD A CRUISE SHIP TO COZUMEL, THE WEATHER SPARKLING and an Absolut and soda in hand, Marty Bradley stared at the Gulf of Mexico from inside a locked suite, his silent misery fed by thoughts of betrayal, financial ruin, and even physical danger.

He had brought sixty employees on the gleaming white ship for his company's annual blowout of dancing, gambling, and sunbathing, a reward for meeting their sales targets. But all Bradley could think of now was armed guards, locksmiths, and lie detector tests- and which of the employees on board had sold him out and gotten away with the score of their lives.

Just twenty-four hours ago, while he had been packing for the cruise, a white van had backed into an alleyway behind his Miami warehouse. Some men climbed from the van and managed to twist the dead bolt, tear off the rear metal door, and enter the warehouse around 8 P.M. Once inside, they knew exactly what to look for.

Shortly afterward, the distribution manager, Rene Perez, returned from his errand at Dadeland Mall and swung past the back alley as was his habit, partly because he was responsible for keeping it clear and partly because Bradley was his brother-in-law. Perez felt protective and viewed the business as a family affair.

Usually the narrow, dimly lit alley was empty. But tonight Perez saw the white van parked outside the warehouse, its motor running and its side door open. He turned and drove toward it along the dusty street. As he angled to park, a man in a long-sleeved T-shirt holding something in his hand ran from the warehouse and leapt into the van as it pulled out, tires screeching.

Perez followed, peeling down the alley behind the warehouse, almost crashing into a garbage dumpster as he struggled, unsuccessfully, to make out the license plate through the uneven street light. After about fifty yards the van barreled north onto another side street and disappeared into Miami's traffic-clogged arteries.

Stunned, Perez stopped and called Bradley at home to tell him about the burglary.



BRADLEY'S COMPANY, BIOMED PLUS, THE NATION'S LARGEST PRIvate wholesale distributor of blood products, sells fragile plasma derivatives and other specialty medicines to doctors' offices, hospitals, and even competing wholesale companies.

The thieves had headed directly for a freezer that contained blood products destined for patients with compromised immune systems, hemophilia, and other rare disorders. All told, they had taken 344 vials of clear liquids that for many patients meant the difference between life and death. Some of the vials cost almost $4,000 apiece. The heist was worth about $335,000.

What bothered Bradley most was not what they had taken but when. The break-in occurred just hours after the delivery of a shipment that included a rare formula called NovoSeven to help hemophiliacs form blood clots. The thieves had taken all of it. Bradley spent the next day- in the hours before boarding the cruise- hiring an armed security guard for $8,000 a month, repairing the damaged door, and installing new locks and metal gates for $150,000. He also arranged for several of his employees to take lie detector tests.

Then he reported the theft to the Bureau of Statewide Pharmaceutical Services, a regulatory requirement that was sure to solve nothing. The inspector he knew there, Cesar Arias, a tousled Cuban-American with a chipped front tooth whose heart was certainly in his job, had no juice whatsoever. One glance at the man's car, a dilapidated blue Buick that looked like it had been pulled off a junk heap, told the story of his agency's budget woes.

The local cops took a report, but they were too busy chasing cocaine and other street drugs to care much about a theft of clotting factor.

But Bradley knew the stolen vials posed a serious danger. The medicine inside was for critical care. It had to remain motionless at a constant temperature and could only be transported with careful planning. At best, it would become useless to a patient and at worst, might do harm. Bradley also worried that the men in the van would return. Or that next time they would come back armed when his employees were there.

Bradley shared these fears with two of his managers, who also stayed in their cabins during the cruise, drinking and avoiding the festivities. On the last day during the group photograph, the three men looked uneasy amid the smiling, well-tanned sales force.

Bradley was in the ship's cocktail lounge waiting to disembark when his cell phone rang. His purchasing manager, Marlene Caceras, was calling about a deal that had been offered in Bradley's absence. A small pharmaceutical wholesale company, the Stone Group, had called and sent faxes offering to sell some plasma derivatives. Bradley had done business with the fledgling company before.

The pharmaceutical wholesale market operates as an all-hours auction, with deals and discounts materializing suddenly and medicine passing through many hands. And while few patients know that these middlemen exist, much of the nation's medicine passes through companies like Bradley's BioMed Plus and the Stone Group. On this deal, the Stone Group had made a typical pitch.

But as Caceras read off the details of the offer, Bradley said, "I don't believe it." Everything she mentioned-including twenty-two vials of NovoSeven at 1.2 milligrams, another twenty-nine at 4.8 milligrams, along with specific amounts of Gammimune, Gammagard, and Iveegam, all for the steeply discounted price of $229,241-was identical to his list of stolen goods, right down to the specific quantities. The medicine was too rare and was almost never traded freely. Bradley knew the medicine was his.



Copyright © 2005 by Katherine Eban

All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording,
or any information storage and retrieval system, without permission in writing from the publisher.

Requests for permission to make copies of any part of
the work should be mailed to the following address:
Permissions Department, Harcourt, Inc.,
6277 Sea Harbor Drive, Orlando, Florida 32887-6777.




Library of Congress subject headings for this publication:
Pharmaceutical policy -- United States.
Drug adulteration.
Drugs -- Safety measures.
Product counterfeiting.
Fraud -- United States.
Pharmaceutical Preparations -- supply & distribution -- United States.
Consumer Advocacy -- United States.
Government Regulation -- United States.
Legislation, Drug -- United States.